-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Initiates Coverage On Lycia Therapeutics with Outperform Rating, Announces Price Target of $43

Benzinga·11/17/2026 11:38:51
Listen to the news
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Lycia Therapeutics (NASDAQ:LYCA) with a Outperform rating and announces Price Target of $43.